A recent study indicated that EMMPRIN could enhance VEGF expression of stromal fibroblasts and carcinoma cells to stimulate tumour angiogenesis via the PI3K-Akt signalling pathway (Tang et al, 2005, 2006). This evidence concerns the gene AKT1 and neoplasm.